Search Results 831-840 of 16067 for 78%

  1. A Study To Understand Attitudes Towards Hepatitis Viral Load Testing That Could Impact Testing Rates - Mayo Clinic

    Understanding these attitudes is a necessary first step to developing effective intervention strategies for liver cancer prevention. Participation eligibility.

  2. Gastroenterology and Hepatology - Clinical trials

    Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, ...

  3. Endovascular Therapy Following Imaging Evaluation For Ischemic Stroke 3 - Mayo Clinic

    About this study. This is a study to evaluate the hypothesis that FDA cleared thrombectomy devices plus medical management leads to superior clinical ...

  4. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    The purpose of this study is to assess the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose ...

  5. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. About this study. Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public ...

  6. Clinical trials - Gastroenterology and Hepatology

    Other enteropathies will also be included: collagenous sprue, idiopathic sprue, lymphocytic enterocolitis, idiopathic enteropathies, collagenous gastritis, ...

  7. Medical Research & Education - Mayo Clinic News Network

    77 · 78 · 79 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...

  8. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

    A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer.

  9. Publications - Mauricio A. Villavicencio, M.D., M.B.A. - Mayo Clinic

    2020 Aug; 272(2):e75-e78. View PubMed; Moonsamy P, Axtell AL, Ibrahim NE, Funamoto M, Tolis G, Lewis GD, D'Alessandro DA, Villavicencio MA. Survival After ...

  10. Publications - Timothy D. Lyon, M.D. - Mayo Clinic

    2016 Jul 1; 311 (1):F78-84 Epub 2016 May 11. View PubMed; Zhang Z, Lyon TD, Kadow BT, Shen B, Wang J, Lee A, Kang A, Roppolo JR, de Groat WC, Tai C ...